Plus Therapeutics, Inc. (PSTV) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -6.24M | -6.26M | -2.55M | -5.8M | -6.17M | -1.21M | -3.68M | -1.15M | -4.51M | -1.88M | -2.4M | -2.78M | -5.79M | -2.23M | -4.22M | -2.64M | -3.88M | -2.62M | -2.25M | -2.4M |
| Operating CF Margin % | -606.81% | -457.72% | -182.39% | -417.12% | -582.81% | -85.76% | -252.75% | -89.91% | -269.11% | -143.26% | -193.47% | -149.84% | -1144.86% | -1479.47% | -5783.56% | - | - | - | - | - |
| Operating CF Growth % | -1.07% | -416.68% | 30.76% | -404.17% | -36.76% | 35.62% | -53.4% | 58.6% | 22.1% | 15.8% | 43.18% | -5.23% | -49.46% | 14.86% | -87.56% | -10.05% | -28.94% | 18.61% | 2.09% | -70.26% |
| Net Income | -6.95M | -5.71M | -4.42M | 5.15M | -17.4M | -3.9M | -2.87M | -2.94M | -3.26M | -3.81M | -3.22M | -1.48M | -4.8M | -5.66M | -5.22M | -5.28M | -4.12M | -4.16M | -3.72M | -2.8M |
| Depreciation & Amortization | 109K | 224K | 86K | 121K | 146K | 103K | 232K | 202K | 186K | 65K | 245K | 188K | 187K | 159K | 224K | 130K | 147K | 129K | 87K | 94K |
| Stock-Based Compensation | 1.02M | 713K | 527K | 152K | 148K | 128K | 125K | 151K | 146K | 141K | 148K | 140K | 140K | 130K | 129K | 167K | 180K | 181K | 180K | 138K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -121K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4K | -122K | 3K | -6.72M | 12.37M | 88K | -1.01M | -1.17M | 17K | 268K | 59K | 53K | 68K | 208K | 53K | 141K | 104K | 413K | 182K | 132K |
| Working Capital Changes | -419K | -1.36M | 1.26M | -4.5M | -1.44M | 2.37M | -156K | 2.61M | -1.6M | 1.58M | 368K | -1.68M | -1.38M | 2.93M | 591K | 2.2M | -191K | 808K | 1.02M | 37K |
| Change in Receivables | -1.03M | 0 | 0 | -1.02M | 571K | -571K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73K | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 489K | 688K | -1.13M | 0 | 0 | 0 | 966K | 403K | -43K | 384K | 0 | 0 | 0 | 4.5M | 0 | 2.18M | -650K | 1.73M | 1M | -122K |
| Cash from Investing | -8.53M | -1.08M | 1.3M | -4.63M | 3.56M | 64K | -9K | -3.8M | -364K | -42K | -10K | -11K | -97K | -11K | -33K | -138K | -577K | 2K | -4K | 4K |
| Capital Expenditures | -818K | -30K | -34K | -7K | -3K | -11K | -14K | -81K | -40K | -42K | -10K | -11K | -97K | -128K | -33K | -138K | -210K | -10K | -54K | 4K |
| CapEx % of Revenue | 79.57% | 2.19% | 2.43% | 0.5% | 0.28% | 0.78% | 0.96% | 6.33% | 2.39% | 3.2% | 0.81% | 0.59% | 19.17% | 84.77% | 45.21% | - | - | - | - | - |
| Acquisitions | 0 | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -23K | 0 | -7.76M | 30K | 0 | 0 | -545K | 0 | 0 | 0 | 0 | 0 | 117K | 0 | 0 | -367K | 12K | 50K | 0 |
| Cash from Financing | 9.04M | 2.8M | 12.31M | 2.8M | 12.4M | 0 | 0 | 6.96M | -776K | -529K | 2.52M | 961K | 493K | 99K | 6.43M | -371K | 7.29M | -258K | 6.37M | 5.11M |
| Debt Issued (Net) | -100K | 750K | 1.49M | 0 | -7M | 0 | 0 | -302K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -402K | -268K | 0 | -2K |
| Equity Issued (Net) | 13.64M | -1K | -3.71M | 1K | 19.4M | 0 | -45K | 7.26M | -374K | -126K | 2.92M | 1.36M | 895K | 501K | 6.83M | 31K | 7.69M | 10K | 6.37M | 5.11M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 220K | -220K | 0 | 0 | 0 | 0 | -374K | -126K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -4.5M | 2.05M | 14.52M | 2.79M | 0 | 0 | 45K | 0 | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -5.74M | -4.53M | 11.06M | -7.63M | 9.79M | -1.15M | -3.69M | 2.01M | -5.65M | -2.45M | 111K | -1.83M | -5.4M | -2.15M | 2.18M | -3.15M | 2.84M | -2.88M | 4.12M | 2.71M |
| Free Cash Flow | -7.06M | -6.29M | -2.58M | -5.8M | -6.17M | -1.22M | -3.69M | -1.78M | -4.55M | -1.92M | -2.41M | -2.79M | -5.89M | -2.25M | -4.25M | -2.78M | -4.45M | -2.63M | -2.31M | -2.4M |
| FCF Margin % | -686.38% | -459.91% | -184.32% | -417.63% | -583.1% | -86.54% | -253.71% | -138.86% | -271.5% | -146.46% | -194.27% | -150.43% | -1164.03% | -1486.75% | -5828.77% | - | - | - | - | - |
| FCF Growth % | -14.27% | -414.48% | 30.29% | -226.86% | -35.62% | 36.45% | -53.34% | 36.32% | 22.7% | 14.34% | 43.38% | -0.4% | -32.27% | 14.77% | -84.6% | -15.99% | -44.11% | 19.7% | 0.35% | -31.52% |
| FCF per Share | -1.06 | -2.02 | -59.92 | -693.88 | -10597.58 | -5181.48 | -11755.35 | -4132.92 | -26337.83 | -10685.70 | -18672.39 | -27785.77 | -63469.36 | -2137.67 | -58146.08 | -46810.07 | -77643.11 | -5447.02 | -65165.86 | -79502.50 |
| FCF Conversion (FCF/Net Income) | 0.90x | 1.10x | 0.58x | -1.13x | 0.35x | 0.31x | 1.28x | 0.39x | 1.38x | 0.49x | 0.75x | 1.87x | 1.21x | 0.39x | 0.81x | 0.50x | 0.94x | 0.63x | 0.60x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 539K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |